John Marker

1.4k total citations · 1 hit paper
7 papers, 1.2k citations indexed

About

John Marker is a scholar working on Genetics, Immunology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, John Marker has authored 7 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Immunology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in John Marker's work include Diabetes and associated disorders (6 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (4 papers). John Marker is often cited by papers focused on Diabetes and associated disorders (6 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (4 papers). John Marker collaborates with scholars based in United States and Italy. John Marker's co-authors include Noel K. Maclaren, Anjli Kukreja, Mark A. Exley, Svetlana Ten, Zhongsheng Sun, Karen Lin‐Su, Chenhui Zhang, Steven A. Porcelli, Maureen M. Sanz and Brian Wilson and has published in prestigious journals such as Journal of Clinical Investigation, Annals of the New York Academy of Sciences and Journal of Autoimmunity.

In The Last Decade

John Marker

7 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multiple immuno-regulatory defects in type-1 diabetes

2002 547 citations Anjli Kukreja, John Marker et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Marker United States	6	858	597	241	192	66	7	1.2k
Evridiki Sgouroudis Canada	11	977 1.1×	539 0.9×	205 0.9×	124 0.6×	120 1.8×	13	1.3k
Mériam Belghith Tunisia	7	503 0.6×	375 0.6×	188 0.8×	144 0.8×	55 0.8×	13	794
Hanne E. Akselsen Norway	20	533 0.6×	703 1.2×	375 1.6×	368 1.9×	38 0.6×	28	1.2k
M E Fisfalen United States	10	424 0.5×	472 0.8×	80 0.3×	273 1.4×	37 0.6×	14	763
Chantal Bécourt France	12	583 0.7×	208 0.3×	146 0.6×	103 0.5×	81 1.2×	18	768
Maigan A. Hulme United States	10	499 0.6×	425 0.7×	300 1.2×	230 1.2×	97 1.5×	10	872
Leonie Oxbrow Australia	9	338 0.4×	396 0.7×	276 1.1×	175 0.9×	76 1.2×	10	664
J. Braun Germany	12	481 0.6×	714 1.2×	166 0.7×	351 1.8×	34 0.5×	16	1.1k
Peter Eerligh Netherlands	12	290 0.3×	285 0.5×	129 0.5×	106 0.6×	34 0.5×	19	576
Yoshikuni Sawai Japan	8	336 0.4×	352 0.6×	74 0.3×	209 1.1×	36 0.5×	17	640

Countries citing papers authored by John Marker

Since Specialization

Citations

This map shows the geographic impact of John Marker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Marker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Marker more than expected).

Fields of papers citing papers by John Marker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Marker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Marker. The network helps show where John Marker may publish in the future.

Co-authorship network of co-authors of John Marker

This figure shows the co-authorship network connecting the top 25 collaborators of John Marker. A scholar is included among the top collaborators of John Marker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Marker. John Marker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ergun-Longmire, Berrin, John Marker, Adina Zeidler, et al.. (2004). Oral Insulin Therapy to Prevent Progression of Immune‐Mediated (Type 1) Diabetes. Annals of the New York Academy of Sciences. 1029(1). 260–277. 53 indexed citations

2.

Kukreja, Anjli, John Marker, Chenhui Zhang, et al.. (2002). Multiple immuno-regulatory defects in type-1 diabetes. Journal of Clinical Investigation. 109(1). 131–140. 28 indexed citations

3.

Kukreja, Anjli, John Marker, Chenhui Zhang, et al.. (2002). Multiple immuno-regulatory defects in type-1 diabetes. Journal of Clinical Investigation. 109(1). 131–140. 497 indexed citations

4.

Kukreja, Anjli, John Marker, Chenhui Zhang, et al.. (2002). Multiple immuno-regulatory defects in type-1 diabetes. Journal of Clinical Investigation. 109(1). 131–140. 547 indexed citations breakdown →

5.

Kukreja, Anjli, et al.. (2002). NKT Cell Defects in NOD Mice Suggest Therapeutic Opportunities. Journal of Autoimmunity. 19(3). 117–128. 16 indexed citations

6.

Marker, John, et al.. (2001). Immunopathology of immune-mediated (type 1) diabetes.. PubMed. 21(1). 15–30. 2 indexed citations

7.

Maclaren, Noel K., et al.. (2001). Autoimmune Hypogonadism as Part of an Autoimmune Polyglandular Syndrome. Journal of the Society for Gynecologic Investigation. 8(1_suppl). S52–S54. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact